Recent

% | $
Quotes you view appear here for quick access.

Hyperion Therapeutics, Inc. Message Board

  • rrtzrealmd rrtzrealmd Feb 25, 2014 11:06 AM Flag

    HAW!!!...gotta laugh!...

    ...released data this am for its "Phase 2 trial of glycerol phenylbutyrate (GPB) for the treatment of hepatic encephalopathy (HE)" which showed it worked better than a "placebo"...as my daughters too frequently say to me, "well, DUHHHHH!"...feeding them an ammonia scavenger is better than doing NOTHING at all!...I am soooooo surprised!!!...HAW!!!...

    ...BUT, how does it compare with the current therapies used to treat HE?...is it safer and/or more effective?...more importantly, is it COST effective?...I mean, after all, the currently accepted therapies are a LOT cheaper; how much is society willing to spend to prevent HE -- usually a symptom of end-stage cirrhosis...

    ...and did anyone notice how this press release came just a couple of days before the fourth quarter earnings release?...I wonder what that could mean?...HAW!!!!....

    SortNewest  |  Oldest  |  Most Replied Expand all replies
 
HPTX
46.080.00(0.00%)Apr 23 4:00 PMEDT